Back to News
Market Impact: 0.25
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat
Source: 247wallst.com
Healthcare & BiotechMarket Technicals & Flows
Moderna shares rose 8% to $147.37 in Friday morning trading, significantly outperforming a quiet biotech sector and only modest gains in broader U.S. equities. The article identifies a notable single-stock rally but provides no catalyst, earnings update, or guidance change.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
MRNA0.45
More News
- H.C. Wainwright raises Tempus AI stock price target to $66
- Berenberg raises Merck stock price target on cancer drug data
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- ‘Worrying Times’ for Bonds as 10-Year Yield Nears 5%
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports
- Investors brace for possible rate hike at uncertain Fed meeting